San Francisco, CA7 Active Studies

Head and Neck Cancer Clinical Trials in San Francisco, CA

Find 7 actively recruiting head and neck cancer clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

7
Active Trials
7
Sponsors
1,746
Enrolling

Recruiting Head and Neck Cancer Studies in San Francisco

About Head and Neck Cancer Clinical Trials in San Francisco

Head and neck cancers develop in the mouth, throat, larynx, sinuses, or salivary glands. HPV-related oropharyngeal cancers have been increasing in prevalence. Treatment includes surgery, radiation, chemotherapy, and immunotherapy.

There are currently 7 head and neck cancer clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 1,746 participants. Research is being sponsored by Bicara Therapeutics, Johnson & Johnson Enterprise Innovation Inc., Corbus Pharmaceuticals Inc. and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Head and Neck Cancer Clinical Trials in San Francisco — FAQ

Are there head and neck cancer clinical trials in San Francisco?

Yes, there are 7 head and neck cancer clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What head and neck cancer treatments are being tested?

The 7 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for head and neck cancer.

Data updated October 8, 2026 from ClinicalTrials.gov